20.72
0.08 (0.39%)
Penutupan Terdahulu | 20.64 |
Buka | 20.22 |
Jumlah Dagangan | 936,866 |
Purata Dagangan (3B) | 1,903,753 |
Modal Pasaran | 1,380,101,120 |
Harga / Pendapatan (P/E Ke hadapan) | 1.11 |
Harga / Jualan (P/S) | 1.39 |
Harga / Buku (P/B) | 8.89 |
Julat 52 Minggu | |
Tarikh Pendapatan | 30 Jul 2025 - 4 Aug 2025 |
Margin Keuntungan | -18.71% |
Margin Operasi (TTM) | -14.71% |
EPS Cair (TTM) | -2.79 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 22.30% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 320.75% |
Nisbah Semasa (MRQ) | 2.30 |
Aliran Tunai Operasi (OCF TTM) | 13.94 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 67.48 M |
Pulangan Atas Aset (ROA TTM) | -6.17% |
Pulangan Atas Ekuiti (ROE TTM) | -92.31% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Devices (US) | Menurun | Bercampur |
Medical Devices (Global) | Menurun | Bercampur | |
Stok | Tandem Diabetes Care, Inc. | Menurun | Menurun |
AISkor Stockmoo
Konsensus Penganalisis | -0.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 0.5 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | 0.5 |
Purata | 0.13 |
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days. |
|
Sektor | Healthcare |
Industri | Medical Devices |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 0.88% |
% Dimiliki oleh Institusi | 111.54% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Sessa Capital Im, L.P. | 31 Mar 2025 | 4,466,307 |
Paradice Investment Management Llc | 31 Mar 2025 | 1,649,907 |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 59.00 (Canaccord Genuity, 184.75%) | Beli |
Median | 24.00 (15.83%) | |
Rendah | 20.00 (Mizuho, -3.48%) | Pegang |
20.00 (Wells Fargo, -3.48%) | Pegang | |
Purata | 28.22 (36.20%) | |
Jumlah | 3 Beli, 6 Pegang | |
Harga Purata @ Panggilan | 19.72 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Citigroup | 22 May 2025 | 24.00 (15.83%) | Pegang | 20.64 |
04 Mar 2025 | 24.00 (15.83%) | Pegang | 19.49 | |
Baird | 01 May 2025 | 24.00 (15.83%) | Pegang | 19.98 |
Canaccord Genuity | 01 May 2025 | 59.00 (184.75%) | Beli | 19.98 |
Piper Sandler | 01 May 2025 | 30.00 (44.79%) | Beli | 19.98 |
Stifel | 01 May 2025 | 31.00 (49.61%) | Beli | 19.98 |
Wells Fargo | 01 May 2025 | 20.00 (-3.47%) | Pegang | 19.98 |
03 Mar 2025 | 22.00 (6.18%) | Pegang | 20.78 | |
Mizuho | 10 Apr 2025 | 20.00 (-3.47%) | Pegang | 17.04 |
Morgan Stanley | 05 Mar 2025 | 22.00 (6.18%) | Pegang | 19.11 |
Goldman Sachs | 03 Mar 2025 | 24.00 (15.83%) | Pegang | 20.78 |
Papar semua |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
06 May 2025 | Pengumuman | Tandem Diabetes Care Announces Upcoming Conference Presentations |
30 Apr 2025 | Pengumuman | Tandem Diabetes Care Announces First Quarter 2025 Financial Results |
03 Apr 2025 | Pengumuman | Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025 |
19 Mar 2025 | Pengumuman | Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes |
18 Mar 2025 | Pengumuman | Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |